ArticlePDF Available

A remarkable food allergy in children: cashew nut allergy

Authors:
  • Dr. Sami Ulus Maternity and Children Research and Training Hospital, Ankara, Turkey

Abstract and Figures

Objective: The prevalence of cashew nut allergy is increasing. Clinical reaction to cashew nuts may be severe, including anaphylaxis. In this study, we aimed to evaluate the frequency of cashew nut sensitivity in a group of children with food allergy and the clinical features and course of cashew nut allergy. Material and methods: A retrospective chart review was performed on 516 children who presented with food allergy at a pediatric allergy department. Individuals sensitized to cashew nuts were examined. Results: Cashew nut sensitization was detected in 17 (64.7% male; mean age of symptom onset, 14 months) of 516 patients with food allergy. Skin symptoms were the most frequent clinical presentation, followed by gastrointestinal symptoms. Overall, 29.4% of the patients presented with anaphylaxis. All anaphylactic reactions were developed after the first consumption of cashew nuts. Of the cashew nut-sensitized patients, 82.3% were diagnosed with moderate-to-severe atopic dermatitis, and all of them had multiple food allergies. During the follow-up, 90% of the patients who had cashew nut sensitization and co-existing food allergies to cow's milk and/or hen's egg developed tolerance to cow's milk and/or hen's egg, but none of the patients could tolerate cashew nut ingestion. Conclusion: Cashew nut is a potent allergen, causing severe allergic reactions that persist long term compared with other food allergies. Early onset of moderate-to-severe atopic dermatitis and multiple food allergies are remarkable co-existing conditions in children who have been diagnosed with cashew nut allergy. Pediatricians should be aware of this emerging food allergy.
Turkish
Archiv es of
Pediatrics
ORIGINAL ARTICLE
DOI: 10.5152/TurkArchPediatr.2020.20111
A remarkable food allergy in children: cashew nut allergy
Ayşegül Ertuğrul , İlknur Bostancı , Serap Özmen
Department of Pediatric Allergy and Immunology, Health Science University Dr. Sami Ulus Maternity and Children Training and Research Hospital, Ankara,
Turkey
What is already known
on this topic?
Recent studies on cashew nut
allergy suggest that the prev-
alence of cashew nut allergy
is increasing with raising con-
sumption. Clinical reaction to
cashew nuts may be severe,
suggesting high potency com-
parable with other tree nuts
and peanuts. The allergen-
ic potential of cashew nuts is
an underestimated important
healthcare problem.
What this study adds on
this topic?
Most of the children in this study
were sensitized to cashew nuts
without ever consuming ca-
shew nuts in the infancy period.
Early onset of moderate-to-se-
vere atopic dermatitis and mul-
tiple food allergies are remark-
able co-existing conditions in
children who have been diag-
nosed with a cashew nut aller-
gy. Cashew nut allergy is asso-
ciated with a significant risk of
anaphylaxis; therefore, ana-
phylaxis should be considered
when evaluating children with
suspected cashew nut allergy.
Content of this journal is licensed
under a Creative Commons
Attribution-NonCommercial 4.0
International License.
Corresponding Author:
İlknur Bostancı
ilknurbirol@hotmail.com
Received: 20.05.2020
Accepted: 11.11.2020
Available Online Date: 12.01.2021
turkarchpediatr.org
ABSTRACT
Objective: The prevalence of cashew nut allergy is increasing. Clinical reaction to cashew nuts
may be severe, including anaphylaxis. In this study, we aimed to evaluate the frequency of ca-
shew nut sensitivity in a group of children with food allergy and the clinical features and course
of cashew nut allergy.
Material and Methods: A retrospective chart review was performed on 516 children who pre-
sented with food allergy at a pediatric allergy department. Individuals sensitized to cashew
nuts were examined.
Results: Cashew nut sensitization was detected in 17 (64.7% male; mean age of symptom onset,
14 months) of 516 patients with food allergy. Skin symptoms were the most frequent clinical pre-
sentation, followed by gastrointestinal symptoms. Overall, 29.4% of the patients presented with
anaphylaxis. All anaphylactic reactions were developed after the first consumption of cashew
nuts. Of the cashew nut–sensitized patients, 82.3% were diagnosed with moderate-to-severe
atopic dermatitis, and all of them had multiple food allergies. During the follow-up, 90% of the
patients who had cashew nut sensitization and co-existing food allergies to cow’s milk and/or
hen’s egg developed tolerance to cow’s milk and/or hen’s egg, but none of the patients could
tolerate cashew nut ingestion.
Conclusion: Cashew nut is a potent allergen, causing severe allergic reactions that persist long
term compared with other food allergies. Early onset of moderate-to-severe atopic dermatitis
and multiple food allergies are remarkable co-existing conditions in children who have been
diagnosed with cashew nut allergy. Pediatricians should be aware of this emerging food al-
lergy.
Keywords: Anaphylaxis, cashew nut, IgE-mediated allergy, sensitization, tree nut allergy
Cite this article as: Ertuğrul A, Bostancı İ, Özmen S. A remarkable food allergy in children: cashew nut allergy.
Turk Arch Pediatr 2021; 56(2): 131-5.
131
Introduction
Tree nut allergy aects over 2% of children (1). Recent studies on cashew nuts (CNs) suggest
that the prevalence of CN allergy is increasing with raising consumption (2). In the 2017–2018
season, CN production raised by 32% over the previous decade worldwide. The biggest ca-
shew consumers in the world are India, USA, Germany, Netherlands, and the United Kingdom
(3). Cashew nut allergy seems to have become a significant problem, not only in these places
but also in other regions, because of the increase in consumption over the past years (4).
Nuts are frequently consumed as snacks in Turkey. Sunflower seeds are the most commonly
consumed snacks, followed by mixed nuts (common constituents of mixed nuts: hazelnuts,
pistachios, almonds, walnuts, peanuts, and CNs) in the traditional eating habits of Turkey (5).
Parallel to the growing trend of CN consumption throughout the previous 10 years all over
the world, we suggest that the rate of CN sensitization is also likely to increase in Turkey as
reported in the previous studies (2).
132
Cashew nut allergy presents most commonly in the first five
years of life (range, 2 months to 27 years), with typical rap-
id-onset immunoglobulin E (IgE)-mediated symptoms (1, 2).
Clinical reaction to CNs may be severe, including anaphylaxis,
suggesting high potency comparable with other tree nuts and
peanuts (2, 6). The mainstay of therapy in CN allergy is avoid-
ance of CNs; however, this is not easy to provide in patients
with CN allergy because it exists in many food products (2). The
majority of children allergic to hen’s egg or cow’s milk often de-
velop tolerance over time, but CN allergy tends to show lifelong
persistence similar to other nuts (1).
Although CN allergy is a serious health problem in children,
it remains understudied in comparison to peanuts and needs
to be underscored as a potent food allergen. In this study, we
present the patients who were sensitized to CNs in a group of
children with food allergy attending a pediatric allergy clinic.
We assessed the clinical features and course of CN allergy.
Material and Methods
A retrospective chart review was performed on 516 children
less than 18 years of age who presented with food allergy over
a 24-month period at the pediatric allergy department of a ter-
tiary care children’s hospital. Food allergy diagnosis was based
on the combination of clear-cut history, typical clinical presen-
tation, positive skin prick test (SPT)/specific IgE, or oral food
challenge (OFC) test (7).
Skin prick test with CN was not applied to all children (n=516)
with food allergy. Among these children, those with a history
of allergic reaction to CNs and/or pistachios were evaluated
for CN allergy in the clinic, but others were not prick tested
with CNs routinely. A total of 17 patients sensitized to CNs (evi-
dence of nut-specific IgE shown by a positive SPT [Stallergenes,
France]) were recruited in the study. A positive SPT was defined
as a mean wheal diameter at least 3 mm greater than the neg-
ative control. We used the ratio defined as histamine equivalent
prick (HEP)-index diameter. We divided the average diameter
of allergen-induced wheal by the average diameter of hista-
mine-induced wheal.
Tolerance was defined for patients whose first OFC was posi-
tive and last OFC was negative during the follow-up. Anaphy-
laxis was defined according to the clinical criteria reported in
“Anaphylaxis: guidelines from the European Academy of Aller-
gy and Clinical Immunology” (8). Hannifin and Rajka criteria
were used to confirm the diagnosis of atopic dermatitis (AD)
(9). The SCORing Atopic Dermatitis (SCORAD) index is used to
assess the severity of AD. Scores below 25 were classified as
mild, scores 25–50 were classified as moderate, and scores
over 50 were classified as severe AD (10).
Ethical approval was received from Keçiören Training and Re-
search Hospital Ethics Comity (protocol number 2012-KAEK-
15/2090). The study was conducted in accordance with the
Declaration of Helsinki.
Statistical analysis
Among the descriptive statistics, continuous variables were
shown as mean and standard deviation (SD). For data not nor-
mally distributed, median with data range (minimum to max-
imum or interquartile range) was used. Categorical variables
are shown as number and percentages. The Mann-Whitney
U test was used for the comparison of continuous inter-group
values. All analyses were performed with IBM SPSS Statistics,
version 15.
Results
A total of 17 patients sensitized to CNs were recruited in the
study. Patients were diagnosed with CN allergy with the com-
bination of clear-cut history, typical clinical presentation, and
positive SPT or OFC. Patients with a history of anaphylaxis af-
ter CN ingestion (n=5) and positive SPT with CN were not chal-
lenged. Of 17 patients, four were not challenged because their
parents did not approve the OFC. All four patients had a posi-
tive SPT with CN with a wheal size greater than 10 mm, which is
the reported cuto value to predict clinical reactivity for CN (11).
Cashew nut sensitization was detected in 17 of 66 patients with
tree nut allergy. A flowchart of the patients is shown in Figure
1. Demographic and clinical characteristics of patients with CN
sensitization are shown in Table 1.
Clinical symptoms after CN intake are shown in Figure 2. Skin
symptoms were the most frequent clinical presentation, fol-
lowed by gastrointestinal symptoms. Of 17 patients, four never
consumed CNs. The parents of these four children did not ap-
prove the OFC, so they were still on an elimination diet. These
four patients had moderate-to-severe AD with multiple food
allergies, and two of them had anaphylaxis with hazelnut.
Anaphylaxis occurred in 9 of 66 patients who were diagnosed
with tree nut allergy. Of those, five were due to CN ingestion.
There was no identified biphasic reaction. None of the ana-
phylactic reactions required hospital admission longer than 24
hours.
Turk Arch Pediatr 2021; 56(2): 131-5Ertuğrul et al. Cashew nut allergy
Table 1. Demographic and clinical characteristics of children
with cashew nut sensitization
Total n (%) (N=17)
Gender
Male 11 (64.7)
Mean age (month)* 37 (11–66)
Mean age of symptom onset (month)* 14 (6–30)
Atopic disease
Atopic dermatitis 14 (82.3)
Anaphylaxis 9 (52.9)
Asthma 5 (29.4)
Sensitization of other tree nut allergy
Pistachio nut 14 (82.3)
Walnut 9 (52.9)
Hazelnut 9 (52.9)
Almond 5 (29.4)
Sensitization of peanut allergy 5 (29.4)
Co-existing food allergy
Egg 8
Cow’s milk 6
Mean total IgE (ku/L)* 309 (16–2.150)
Mean tryptase level (μg/L)* 6.7 (3.8–10.9)
*Minimum–maximum interval. IgE, immunoglobulin E.
133
Of 17 CN-sensitized children, 14 had AD. According to the
SCORAD index, all of these patients were diagnosed as mod-
erate-to-severe AD. All patients with CN sensitization had
multiple food allergies. All patients with CN sensitization had
co-existing sensitization proven by positive SPT with at least
one of the tree nuts, as described in detail in Table 1. Overall,
58.8% of patients with CN sensitization had co-existing chal-
lenge-proved food allergies with cow’s milk and/or hen’s egg.
The mean±SD wheal diameter of SPT with CN was 10.3±6.9 mm.
The mean±SD HEP-index diameter of CN was 1.4±0.85. Patients
were divided into two groups (patients with anaphylactic and
non-anaphylactic CN reactions) according to the clinical re-
actions to CN based on international anaphylaxis guidelines
(8). There was no dierence in the HEP-index diameter or SPT
mean wheal diameter between these two groups (p>0.05). No
dierences were found concerning total IgE, basal tryptase
level, and absolute eosinophil count between the two groups
(p>0.05) (Table 2).
Patients whose parents refused OFC or patients with positive
OFC continued an elimination diet during the follow-up. During
the follow-up (minimum–maximum, 6–24 months), none of the
patients were re-challenged with CN. Two patients had eat-
en CNs in the follow-up period accidentally, and IgE-mediated
clinic symptoms were observed. All of the patients with CN sen-
sitization had still been on an elimination diet. Of the patients
with CN sensitization, 35.2% developed tolerance to some of the
other tree nuts (pistachio nut, walnut, hazelnut, almond, pea-
nut) rather than CN, as shown in Figure 3. Of the patients who
had co-existing food allergies to cow’s milk and/or hen’s egg,
90% developed tolerance to cow’s milk and/or hen’s egg.
Discussion
In this study, results show that CN is causing considerably se-
vere reactions among tree nuts, and CN allergy is associated
with a significant risk of anaphylaxis in children. Most of the
children were sensitized to CN without ever consuming CNs in
the infancy period. Early onset of moderate-to-severe AD and
multiple food allergies are remarkable co-existing conditions in
children who have been diagnosed with CN allergy.
In our study, we found that 3.2% of the 516 children diagnosed
with food allergy were sensitized to CN over a 24-month peri-
od. In Sweden, over a 10-year period, the estimated prevalence
of CN allergy was 6% of food allergic children (12). We suggest
that the dierence may be due to the eating habits and fre-
quency of CN consumption in dierent geographical areas and
awareness of the doctors for the diagnosis of CN allergy. In our
study, 26% of the nut allergic patients were sensitized to CN.
Davoren et al. (6) and Moneret-Vautrin et al. (13) indicated that
12.6% and 41%, respectively, of the nut allergic patients were
sensitized to CNs.
The median age of CN reaction was about 24 months in the
literature (14). In our study, the age of onset of allergic symp-
toms to CN varies between 6 and 30 months, with a mean age
of 14 months. For CN allergy, the ingestion of CNs seems to be
the principal sensitization path, although mechanisms associ-
Turk Arch Pediatr 2021; 56(2): 131-5 Ertuğrul et al. Cashew nut allergy
Table 2. Comparison of children with CN sensitization according to the clinical reactions to CN based on anaphylaxis
Patients Patients with anaphylactic reaction Patients with non-anaphylactic reaction p
Wheal diameter of SPT with CN 20 (10.5–21.5) 6 (5–9) 0.069
Mean HEP-index diameter of CN 1.40 (1.05–1.88) 1.09 (0.88–1.42) 0.268
Total IgE (ku/L) 106 (35–1.643) 74 (38–343) 0.794
Basal tryptase level (μg/L) 8.3 (5.2–8.3) 5.2 (3.8–7.8) 0.154
Absolute eosinophil count (microL) 350 (90–500) 205 (105–487) 0.799
CN, cashew nut; HEP, histamine equivalent prick; IgE, immunoglobulin E; SPT, skin prick test.
All values reported as median (interquartile range).
Figure 1. Flowchart of the study
In 24 months 516 patients were diagnosed as food allergy
Patients with tree-nut-allergy
66/516 (13%)
Patients without tree-nut-allergy
450/516 (87%)
Sensitized with cashew nut
17/66 (26%)
Not sensitized with
cashew nut
49/66 (74%)
Figure 3. Tolerance acquisition to tree nuts in patients with cashew nut
sensitization
Cashew Pistachio Walnut Hazelnut Almond Peanut Cow’s Hen’s
nut nut milk egg
Number of patients
On elimination diet Tolerant
18
16
14
12
10
8
6
4
2
0
Figure 2. Clinical symptoms after cashew nut ingestion
Skin symptoms
(Urticaria, angioedema, redness,
itchiness, atopic dermatitis
exacerbation)
13 patients (100%)
Gastrointestinal symptoms
(Nausea, vomiting, diarrhea)
4 patients (30%)
Respiratory symptoms
(Cough, wheeze, shortness of breath)
3 patients (23%)
4/17 had
never eaten
cashew nut
17 patients with
cashew nut
sensitization
134
ated with poor skin barrier function such as AD have also been
highlighted as an increasing risk factor for the development of
CN allergy (4). Crealey et al. (15) reported that 76% of those
reacting to CNs had eczema (65% of those developing it in the
first six months of life). Compatibly, most of our patients had
moderate-to-severe AD in early life and were sensitized to CNs
without ever consuming them. Our patients’ data supported the
mechanism associated with disrupted skin barrier integrity and
transcutaneous sensitization.
Most of the reported clinical reactions to CNs are moderate to
severe, and fatalities have also been reported (5). Gastrointes-
tinal symptoms are common after skin involvement and more
frequent in comparison to peanut and other tree nut allergies
(16, 17). In this study, skin symptoms were the most common,
followed by gastrointestinal and respiratory symptoms, which
corresponds to previous reports (18). In our study group, five
of 17 patients (29.4%) sensitized with CN presented with ana-
phylactic reaction after ingestion of CNs. Anaphylactic reac-
tion was developed after the first consumption of CNs. Three
of these patients were younger than 12 months, and four of
them had a history of severe AD. Crealey et al. (15) reported
that 53% of children with clinical reaction to CNs presented
with anaphylaxis, and Clark et al. (19) reported more severe
symptoms (more bronchoconstriction and more cardiovascular
symptoms) to CNs compared with peanut allergy. Anaphylaxis
occurring without cutaneous features has previously been re-
ported, but none of our patients presented without cutaneous
features (6). The SPT’s mean wheal diameter, HEP-index di-
ameter, total IgE, basal tryptase level, and absolute eosinophil
count did not dier significantly among patients with anaphy-
lactic and non-anaphylactic CN reactions. The small number
of patients may limit the analysis. Cetinkaya et al. (20) showed
that asthma, egg white allergy, higher serum basal tryptase
levels, and female gender were independent risk factors for
anaphylaxis in children with tree nut allergies.
The cashew plant
(Anacardiumoccidantale L)
, pistachio nut
(Pistaciavera)
, and mango
(Mangiferaindica)
belong to the
Anacardiacea family, and previous studies demonstrated
cross-reactivity to CNs and pistachio (21). Of the patients with
CN sensitization, 82.3% had co-sensitization with pistachio
nut in our group. Because the consumption of mango is very
rare in Turkey, mango allergy was not evaluated. van der Valk
et al. (22) reported in their study evaluating 29 children that
co-sensitization between CNs and pistachio nuts was 98%, but
pistachio nut sensitization was clinically relevant in 34% of the
children. Unless a negative OFC is demonstrated, avoidance of
pistachio nuts must be advised. The other related tree nut aller-
gens should be investigated before avoidance (2).
There were no patients with CN allergy alone; all patients had
multiple food allergies in our study. Overall, 58.8% of our pa-
tients clinically reacted to another food with cow’s milk and/or
hen’s egg. Recent data show that early-onset severe eczema
and egg allergy is a significant risk factor for peanut allergy
(23-25). Most of our patients with CN sensitization had ear-
ly-onset moderate-to-severe eczema, and more than half of
them had hen’s egg and/or cow’s milk allergy. We propose that
not only peanut but also CN allergy is alarming for this group
of patients.
Over 36 months, all of the patients with CN sensitivity were still
on a CN elimination diet, although 90% of these patients devel-
oped clinical tolerance to cow’s milk and/or hen’s egg. During
follow-up with patients in whom OFCs were performed, there
were no patients who developed tolerance to CNs. Prevention
and detection of CN allergy in clinical practice is highly import-
ant, because this potent allergen seems to be responsible for
the long-lived allergy (1).
This study projects experiences in a tertiary allergy clinic but
has some limitations because of the retrospective composi-
tion. The most important limitation of the study was the small
number of participants. The specific IgE level of CNs was not
measured because of the insuciency of the hospital’s labora-
tory. However, in a recent study, it is indicated that SPT with CN
is more predictive than specific IgE for positive OFC (11). Oral
food challenges were not performed on the patients whose
parents did not give written informed consent. In spite of these
facts, it is a real-life study pointing to the life-threatening se-
vere reactions after CN intake in children.
Cashew nut is a potent allergen causing severe and systemic
allergic reactions that persist long term compared with other
food allergies. Cashew nut allergy is associated with a signifi-
cant risk of anaphylaxis; therefore, anaphylaxis should be con-
sidered when evaluating children with a suspected CN aller-
gy. There is a vigorous prevalence of atopy among CN allergic
subjects. Children who have a food allergy to hen’s egg and/
or cow’s milk, with early onset of moderate-to-severe AD, seem
to be at risk.
Ethical Committee Approval: Ethics committee approval was received
for this study from the ethics committee of Keçiören Training and Re-
search Hospital (2012-KAEK-15/2090).
Informed Consent: Patient consent was not obtained due to the retro-
spective design of the study.
Peer-review: Externally peer-reviewed.
Author Contributions: Concept – A.E., İ.B., S.Ö.; Design – A.E., İ.B., S.Ö.;
Supervision – A.E., İ.B., S.Ö.; Funding – A.E., İ.B., S.Ö.; Materials – A.E.,
İ.B., S.Ö.; Data Collection and/or Processing – A.E., İ.B., S.Ö.; Analysis
and/or Interpretation – A.E., İ.B., S.Ö.; Literature Review – A.E., İ.B., S.Ö.;
Writing – A.E., İ.B., S.Ö.; Critical Review – A.E., İ.B., S.Ö.
Conflict of Interest: The authors have no conflicts of interest to de-
clare.
Financial Disclosure: The authors declared that this study has received
no financial support.
References
1. Stiefel G, Anagnostou K, Boyle RJ, et al. BSACI guideline for the di-
agnosis and management of pea nut and tree nut allergy. Clin Exp
Allergy 2017; 47: 719-39. [Crossref]
2. van der Valk JP, Dubois AE, Gerth van Wijk R, Wichers HJ, de Jong
NW. Systematic review on cashew nut allergy. Allergy 2014; 69:
692-8. [Crossref]
3. Nuts & dried fruits Statistical Yearbook 2017/2018. Available from:
https://www.nutfruit.org/files/tech/1524481168_INC_Statistical_
Yearbook_2017-2018.pdf (accessed May 2020).
Turk Arch Pediatr 2021; 56(2): 131-5
Ertuğrul et al. Cashew nut allergy
135
4. Mendes C, Costa j, Vicente AA, Oliveira MBPP, Mafra I. Cashew Nut
Allergy: Clinical Relevance and Allergen Characterisation. Clinic
Rev Allerg Immunol 2019; 57: 1-22. [Crossref]
5. Turan DÇ. Dried Nuts Sector In Turkey, Competition Strategies Be-
tween The Firms And Consumer Trends. Tekirdağ: Namık Kemal
University.2012.
6. Davoren M, Peake J. Cashew nut allergy is associated with a high
risk of anaphylaxis. Arch Dis Child 2005; 90: 1084-5. [Crossref]
7. Muraro A, Halken S, Arshad SH, Beyer K, Dubois AE, Du Toit G. EAA-
CI food allergy and anaphylaxis guidelines. Primary prevention of
food allergy. Allergy 2014; 69: 590-601. [Crossref]
8. Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from
the European Academy of Allergy and Clinical Immunology. Allergy
2014; 69: 1026-45. [Crossref]
9. Hanifin JM. Diagnostic features of atopic dermatitis. Acta Derm
Venereol (Suppl) 1980; 92: 44-7.
10. Stalder J, Taieb A, Atherton D, et al. Severity scoring of atopic der-
matitis: the SCORAD index: consensus report of the european task
force on atopic dermatitis. Dermatology 1993; 186: 23-31. [Crossref]
11. Cetinkaya PG, Karaguzel D, Esenboğa S, et al. Pistachio and ca-
shew nut allergy in childhood: Predictive factors towards devel-
opment of a decision tree. Asian Pac J Allergy Immunol 2019; DOI:
10.12932/AP-281018-0429.
12. Johnson J, Malinovschi A, Alving K, Lidholm J, Borres MP. Ten-year
review reveals changing trends and severity of allergic reactions to
nuts and other foods. Acta Paediatr 2014; 103: 862-7. [Crossref]
13. Moneret-Vautrin DA, Rance F, Kanny G, et al. Food allergy to pea-
nuts in France evaluation of 142 observations. Clin Exp Allergy1998;
28: 1113-9. [Crossref]
14. F. Rancé, E. Bidat, T. Bourrier, Sabouraud D. Cashew allergy: ob-
servations of 42 children without associated peanut allergy. Aller-
gy 2003; 58: 1311-4. [Crossref]
15. Crealey M, Alamin S, Tormey V, Moylett E. Clinical presentation
of cashew nut allergy in a paediatric cohort attending an al-
lergy clinic in the West of Ireland. Ir J Med Sci 2019; 188: 219-22.
[Crossref]
16. van der Valk JPM, van Wijk RG, Dubois AEJ, et al. Multicentre dou-
ble-blind placebo-controlled food challenge study in children sen-
sitized to cashew nut. PLoS One 2016; 11: e0151055. [Crossref]
17. Maloney JM, Rudengren M, Ahlstedt S, Bock SA, Sampson HA. The
use of serum-specific IgE measurements for the diagnosis of pea-
nut, tree nut, and seed allergy. J Allergy Clin Immunol 2008; 122:
145-51. [Crossref]
18. Grigg A, Hanson C, Davis CM. Cashew Allergy Compared To Pea-
nut Allergy In A Us Tertiary Center. Pediatr Asthma Allergy Immunol
2009; 22: 101-4. [Crossref]
19. Clark AT, Anagnostou K, Ewan PW. Cashew nut causes more severe
reactions than peanut: case matched comparison in 141 children.
Allergy 2007; 62: 913-6. [Crossref]
20. Cetinkaya PG, Buyuktiryaki B, Soyer O, Sahiner UM, Sekerel BE.
Factors predicting anaphylaxis in children with tree nut allergies.
Allergy Asthma Proc 2019; 40: 180-6. [Crossref]
21. Garcia F, Moneo I, Fernandez B, et al. Allergy to Anacardiacea: de-
scription of cashew and pistachio nut allergens. J Investig Allergol
Clin Immunol 2000; 10: 173-7.
22. van der Valk JPM, Bouche RE, Gerth van Wijk R, et al. Low percentage
of clinically relevant pistachio nut and mango co-sensitisation in ca-
shew nut sensitised children. Clin Transl Allergy 2017; 7: 8. [Crossref]
23. Du Toit G, Roberts G, Sayre PH, et al. Randomized Trial of Peanut
Consumption in Infants at Risk for Peanut Allergy. N Engl J Med
2015; 372: 803-13. [Crossref]
24. Martin PE, Eckert JK, Koplin JJ, et al. Which infants with eczema are
at a risk of food allergy? Results from a population-based cohort.
Clin Exp Allergy 2015; 45: 255-64. [Crossref]
25. Du Toit G, Roberts G, Sayre PH, et al. Identifying infants at high risk
of peanut allergy: the Learning Early About Peanut Allergy (LEAP)
screening study. J Allergy Clin Immunol 2013; 131: 135-43. [Crossref]
Turk Arch Pediatr 2021; 56(2): 131-5 Ertuğrul et al. Cashew nut allergy
... For example, about 29 % of 516 Turkish children exhibited anaphylactic reactions to cashew nuts in a retrospective chart review (Ertugrul et al., 2021). Class I food allergens such as vicillins, legumins, and 2 S albumins have been identified in cashew nuts and are mainly responsible for the allergenicity of cashew (Mendes, Costa, Vicente, Oliveira, & Mafra, ...
Article
Plant-based foods in recent times have received attention from environmentalists due to their lower impacts on the environment. Additionally, they are found to improve health better than animal-based foods. Despite the benefits associated with plant-based diets, their full adoption faces several interconnected barriers. The review aimed to comprehensively highlight the barriers against plant-based food adoption. It also aimed to outline the progress, trends and supporting factors in plant-based food manufacturing and plant-based food consumption. The review finally discusses strategies to overcome the identified barriers against the adoption of plant-based foods. It was found that aside from social, economic, nutritional, legal, religious, and cultural barriers, most of the raw materials used in manufacturing plant-based foods are sources of major food allergens. Regardless, plant-based alternative food manufacturing is spreading worldwide, and research activities focused on plant-based foods have tripled in the last three years. In conclusion, despite the existing barriers, the plant-based and alternative protein industry appears to thrive, and measures to address the identified barriers have emerged and are yielding a positive impact.
... This suggests a high potency of cashew nut allergens, equivalent to or even higher than that of peanut [14]. Notably, the allergic reactions were triggered in more than three-quarters of cases at the first known exposure [10,12,15,16]. Similar clinical observation in peanut allergy led to the hypothesis that early environmental exposure to peanut (through the impaired skin or the airway) may account for early sensitization [17]. ...
Article
Full-text available
Background: Cashew nuts often cause strong allergic reactions, even exceeding those of peanuts. Ana o 1 (vicilin), Ana o 2 (legumin) and Ana o 3 (2S albumin) are major cashew allergens. Co-sensitization to all three non-homologous cashew nut allergens has been observed. We hypothesize that this might be due to IgE cross-reactivity. Methods: IgE cross-inhibitions were performed with Ana o 1-3 using sera from cashew nut allergic patients. Related hazelnut allergens Cor a 11, 9 and 14 were used as controls. For comparison, IgE cross-reactivity between the hazelnut allergens was investigated using sera from hazelnut allergic patients. Results: Median percentages of cross-inhibitions between Ana o 1-3 were 84-99%. In comparison, medians of cross-inhibitions between hazelnut allergens were 33-62%. The IC50 values revealed the highest IgE affinity to Ana o 3 and Cor a 14. Hazelnut legumin Cor a 9 inhibited IgE-binding to Ana o 1, 2, and 3 with median percentages of 75%, 56%, and 48%, respectively. No cross-reactivity was observed between allergenic vicilins or between 2S albumins from cashew and hazelnut. In silico identified potentially cross-reactive peptides of Ana o 3 overlapped with previously reported IgE epitopes of all three allergens. Conclusions: IgE with high affinity to Ana o 3 that cross-reacts with the other two major non-homologous cashew nut allergens might be responsible for the high allergenic potency of cashew nut. These cross-reactive IgE comprises the major fraction of specific IgE in cashew allergic patients, and might be responsible for cross-reactivity between unrelated tree nuts.
... Clinically relevant allergy toward nuts is often present at an early age (23) and is rarely outgrown (8,24), but the natural course of sensitization and clinical reactions toward multiple nuts cannot always be predicted (25). A study by Andorf et al. (26) that aimed at investigating common clinical patterns in multi foodallergic patients found a high coincidence of cashew and pistachio nut allergy and of walnut, pecan, and hazelnut allergy in the same individuals. ...
Article
Full-text available
Background Tree nut allergy is associated with severe reactions and poly-sensitization to other nuts and peanuts often occurs. There are regional differences in sensitization profiles that result in differences in clinical presentation. Denmark is located in a birch pollen endemic area, which could influence the allergy patterns due to pollen cross-sensitization. Objective This study aimed to investigate patterns of sensitization and clinical reactivity to tree nuts and peanuts and threshold levels for oral food challenges (OFCs) in a Danish cohort of tree nut allergic children, adolescents, and young adults. Methods Forty tree nut allergic subjects were assessed for clinical reactivity to six nuts, i.e., hazelnut, walnut, pistachio, cashew, almond, and peanut, by OFCs or convincing medical history of an immediate allergic reaction or tolerance. Clinical presentation and allergen-specific immunoglobulin E (sIgE) levels together with eliciting dose and rescue medication in OFCs were furthermore assessed. Results Allergy to two or more tree nuts was observed in most cases. Hazelnut-walnut dual allergy was common but not exclusively observed as concomitant allergies. Allergy to cashew was coincided in all but one of the assessed subjects with pistachio allergy. Half of all assessed subjects were allergic to peanuts. Oral symptoms followed by a skin reaction were the most common symptomatology that lead to OFC cessation and subjects often presented with symptoms from two or more organ systems. OFC threshold levels were within the same range, but cashew was distinguished from other nuts by causing allergic symptoms at the lowest dose. Clinical reactivity and the allergy patterns were to some extent reflected by sIgE levels and by correlations in sIgE between the nuts. Conclusions In this Northern European cohort, subjects with clinically relevant tree nut allergy were generally allergic to two or more tree nuts and close to half of them also to peanuts. There were two distinct and independent allergic phenotypes; the majority of hazelnut allergic subjects were also allergic to walnut, and all but one subject with cashew allergy were dual allergic to pistachio. These findings are consistent with a strong sIgE correlation between hazelnut and walnut and a close to total sIgE correlation between cashew and pistachio.
Article
Full-text available
Background: Pistachio and cashew nut, which belong to the same botanical family, are tree nuts that induce serious allergic reactions. Objective: We aimed to determine the predictive factors for pistachio and cashew nut reactivity during oral food challenge (OFC). Methods: A total of 112 pistachio and/or cashew nut sensitized children, aged 58.45 (IQR:40.38-88.32) months, were included. Cutoff values and probability curves for skin prick test (SPT), sIgE, sIgE/Total IgE that predict reactivity were determined for pistachio and cashew nut. Additionally, a diagram was created that can be useful while making a decision for OFC based on SPT and sIgE values. Results: A total of 73 patients underwent OFC with pistachio and/or cashew nut. Twelve children with current anaphylaxis history were not challenged and accepted as allergic. SPT was the only predictive factor for positive pistachio/ cashew nut OFC. According to area under curve (AUC) analysis, SPT was more predictive than sIgE and sIgE/Total IgE both for pistachio and cashew nut. Optimal cutoff values according to "Youden index" for pistachio SPT, sIgE, and sIgE/ Total IgE were 7.25 mm, 4.14 kUA/L, and 1.32%, respectively. And those values for cashew nut SPT, sIgE, and sIgE/Total IgE were 6.25 mm, 1.125 kUA/L, and 3.30%, respectively. The diagram showed that SPT predicted the reactivity together with sIgE better than only the SPT values. Conclusion: SPT was the best predictor for reactivity both for pistachio and cashew nut. Combined use of SPT and sIgE may improve the prediction of reactivity at pistachio and cashew nut OFCs in children.
Article
Full-text available
Background: Cashew nut (CN) allergy appears to be increasing. Reactions are variable and may include anaphylaxis. Aim: To describe the clinical features of CN allergy in a group of children attending an allergy clinic with suspected peanut allergy and confirmed sensitisation to CN. Methods: Patients were identified retrospectively by reviewing the Immunology Database at University Hospital Galway over a 5-year period, Oct. 2010 to Sept. 2015. Patients confirmed sensitised to CN (specific IgE > 0.35 kUa/L, ImmunoCAP Assay) were selected and contacted. Results: Over the 5-year period, 115 children were identified; 102/115 were individually contacted. Of the 102 children, 55 had a history of prior CN exposure with confirmed clinical reaction, 43 had no prior CN exposure, and 4 were sensitised and tolerating CN. For those with clinical CN allergy (N = 55), 30 (55%) were male and median age of onset was 2 years (lower quartile 1.5, upper quartile 4.8). Severity of reaction was graded as mild for 13 children, moderate in 13 additional children, and severe in 29 children. Median CN serum IgE level was 3.2 kUa/L (range 0.36 to > 100) in the clinical reaction group, 2.91 kUa/L (range 0.36 to > 100) in the sensitised group, and 3.4 kUa/L (range 0.94 to 5.21) in those tolerating CN. IgE values were not significantly different between those with mild, moderate, or severe reaction to CN (p = 0.346). Conclusion: Children are ingesting CN at a young age with more than half of allergic reactions reportedly severe in nature. The specific CN IgE value was not helpful in predicting severity of reactions.
Article
Full-text available
Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut pro- teins. Nut allergy is a global disease. Limited epidemiological data suggest varying preva- lence in different geographical areas. Primary nut allergy affects over 2% of children and 0.5% of adults in the UK. Infants with severe eczema and/or egg allergy have a higher risk of peanut allergy. Primary nut allergy presents most commonly in the first five years of life, often after the first known ingestion with typical rapid onset IgE-mediated symp- toms. The clinical diagnosis of primary nut allergy can be made by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a positive skin prick test (SPT) or specific IgE (sIgE) test. Pollen food syndrome is a distinct disorder, usu- ally mild, with oral/pharyngeal symptoms, in the context of hay fever or pollen sensitisa- tion, which can be triggered by nuts. It can usually be distinguish clinically from primary nut allergy. The magnitude of a SPT or sIgE relates to the probability of clinical allergy, but does not relate to clinical severity. SPT of ≥ 8 mm or sIgE ≥ 15 KU/L to peanut is highly predictive of clinical allergy. Cut off values are not available for tree nuts. Test results must be interpreted in the context of the clinical history. Diagnostic food chal- lenges are usually not necessary but may be used to confirm or refute a conflicting his- tory and test result. As nut allergy is likely to be a long-lived disease, nut avoidance advice is the cornerstone of management. Patients should be provided with a comprehen- sive management plan including avoidance advice, patient specific emergency medication and an emergency treatment plan and training in administration of emergency medica- tion. Regular re-training is required.
Article
Full-text available
Background Cashew nut, pistachio nut and mango belong to the Anacardiaceae family and are botanically related. Therefore, cashew nut sensitised children are frequently advised to eliminate cashew nuts and pistachio nuts from their diet. The ‘Improvement of Diagnostic mEthods for ALlergy assessment (IDEAL trial number NTR3572) study showed that cashew nut sensitised children were co-sensitised to pistachio nut in 98% of cases and to mango in 21% of cases. The aim of this follow-up study to IDEAL is to assess the clinical relevance of co-sensitisation to pistachio nut and mango in cashew nut sensitised children. Methods Children were recruited from the study: ‘Improvement of Diagnostic mEthods for ALlergy assessment (IDEAL trial number NTR3572). Inclusion criterion for the IDEAL study was sensitization to cashew nut as demonstrated by either SPT or sIgE, and a clinical history of reactions to cashew nuts or no previous (known) exposure. Sensitized children who were tolerant to cashew nuts were excluded. Inclusion criterion for this IDEAL follow-up study was co-sensitization to pistachio nut, regardless the result of the DBPCFC with cashew nut. In this follow-up study a double-blind placebo-controlled food challenge with pistachio nut and an open food challenge with mango were performed. ResultsTwenty-nine children (mean age of 11.6 years, 62% male) were included. Pistachio nut sensitisation was clinically relevant in only 34% of cashew-sensitised children and only 31% of cashew challenge positive children. None of the children was challenge positive to mango. Conclusion Although co-sensitisation between cashew nut and pistachio nut was observed in 98%, pistachio nut sensitisation was only clinically relevant in 34% of the children. Therefore, a challenge test with pistachio nut is recommended in children with cashew nut and pistachio nut sensitisation.Trial registration The study was registered in the Dutch trial register (registration number 3572) on 10 August 2012 (retrospectively registered)
Article
Full-text available
Cashew plant (Anacardium occidentale L.) is the most relevant species of the Anacardium genus. It presents high economic value since it is widely used in human nutrition and in several industrial applications. Cashew nut is a well-appreciated food (belongs to the tree nut group), being widely consumed as snacks and in processed foods by the majority of world's population. However, cashew nut is also classified as a potent allergenic food known to be responsible for triggering severe and systemic immune reactions (e.g. anaphylaxis) in sensitised/allergic individuals that often demand epinephrine treatment and hospitalisation. So far, three groups of allergenic proteins have been identified and characterised in cashew nut: Ana o 1 and Ana o 2 (cupin superfamily) and Ana o 3 (prolamin superfamily), which are all classified as major allergens. The prevalence of cashew nut allergy seems to be rising in industrialised countries with the increasing consumption of this nut. There is still no cure for cashew nut allergy, as well as for other food allergies; thus, the allergic patients are advised to eliminate it from their diets. Accordingly, when carefully choosing processed foods that are commercially available, the allergic consumers have to rely on proper food labelling. In this sense, the control of labelling compliance is much needed, which has prompted the development of proficient analytical methods for allergen analysis. In the recent years, significant research advances in cashew nut allergy have been accomplished, which are highlighted and discussed in this review.
Article
Full-text available
br/>Few studies with a limited number of patients have provided indications that cashew-allergic patients may experience severe allergic reactions to minimal amounts of cashew nut. The objectives of this multicentre study were to assess the clinical relevance of cashew nut sensitisation, to study the clinical reaction patterns in double-blind placebo-controlled food challenge tests and to establish the amount of cashew nuts that can elicit an allergic reaction.Methods and FindingsA total of 179 children were included (median age 9.0 years; range 2–17 years) with cashew nut sensitisation and a clinical history of reactions to cashew nuts or unknown exposure. Sensitised children who could tolerate cashew nuts were excluded. The study included three clinical visits and a telephone consultation. During the first visit, the medical history was evaluated, physical examinations were conducted, blood samples were drawn and skin prick tests were performed. The children underwent a double-blind placebo-controlled food challenge test with cashew nut during the second and third visits. The study showed that 137 (76.5%) of the sensitised children suspected of allergy to cashew nut had a positive double-blind placebo-controlled food challenge test, with 46% (63) manifesting subjective symptoms to the lowest dose of 1 mg cashew nut protein and 11% (15) developing objective symptoms to the lowest dose. Children most frequently had gastro-intestinal symptoms, followed by oral allergy and skin symptoms. A total of 36% (49/137) of the children experienced an anaphylactic reaction and 6% (8/137) of the children were treated with epinephrine.Conclusion This prospective study demonstrated a strikingly high percentage of clinical reactions to cashew nut in this third line population. Severe allergic reactions, including anaphylaxis requiring epinephrine, were observed. These reactions were to minimal amounts of cashew nut, demonstrated the high potency of this allergens.
Article
Full-text available
Anaphylaxis is a clinical emergency, and all healthcare professionals should be familiar with its recognition and acute and ongoing management. These guidelines have been prepared by the European Academy of Allergy and Clinical Immunology (EAACI) Taskforce on Anaphylaxis. They aim to provide evidence-based recommendations for the recognition, risk factor assessment, and the management of patients who are at risk of, are experiencing, or have experienced anaphylaxis. While the primary audience is allergists, these guidelines are also relevant to all other healthcare professionals. The development of these guidelines has been underpinned by two systematic reviews of the literature, both on the epidemiology and on clinical management of anaphylaxis. Anaphylaxis is a potentially life-threatening condition whose clinical diagnosis is based on recognition of a constellation of presenting features. First-line treatment for anaphylaxis is intramuscular adrenaline. Useful second-line interventions may include removing the trigger where possible, calling for help, correct positioning of the patient, high-flow oxygen, intravenous fluids, inhaled short-acting bronchodilators, and nebulized adrenaline. Discharge arrangements should involve an assessment of the risk of further reactions, a management plan with an anaphylaxis emergency action plan, and, where appropriate, prescribing an adrenaline auto-injector. If an adrenaline auto-injector is prescribed, education on when and how to use the device should be provided. Specialist follow-up is essential to investigate possible triggers, to perform a comprehensive risk assessment, and to prevent future episodes by developing personalized risk reduction strategies including, where possible, commencing allergen immunotherapy. Training for the patient and all caregivers is essential. There are still many gaps in the evidence base for anaphylaxis.
Article
Background: Tree nut (TN) allergies are the most common cause of fatal anaphylaxis and generally are ongoing food allergies throughout life. Objective: To investigate the predicting factors for TN anaphylaxis in children. Methods: Children with TN allergy were divided into anaphylactic and nonanaphylactic groups, those who had an anaphylactic reaction with at least one type of TN and those with any type of reaction other than anaphylaxis with TNs, respectively. Children with TN allergies were evaluated for the predictors of anaphylaxis by using multivariate logistic regression analysis. Results: A total of 184 children (ages 4.9 years; 3.2-6.9 years) with TN allergy were included in the study. Of these, 90 experienced an anaphylactic type of reaction on exposure to at least one type of TNs. Comparisons of the two groups showed that concomitant asthma, skin-prick test, specific immunoglobulin E, total immunoglobulin E, and serum basal tryptase (sBT) levels were significantly higher in the anaphylactic group compared with the nonanaphylactic group. In multivariate analysis, female gender (odds ratio [OR] 4.905 [95% confidence interval {CI}, 1.266-19.001], p = 0.021), sBT levels (OR 2.287 [95% CI, 1.431-3.654], p < 0.001), concomitant egg white allergy (OR 4.135 [95% CI, 1.016-16.481], p = 0.048), and concomitant asthma (OR 3.874 [95% CI, 1.109-13.526], p = 0.034) were risk factors for anaphylaxis. The optimal cutoff value for sBT was 2.06 ng/mL, with a sensitivity of 85.9% and a specificity of 69%, as well as an area under the curve 0.810 (95% CI, 0.717-0.903, p < 0.001). The sBT levels of 1.94 ng/mL and 5.30 ng/mL predicted clinical reactivity at 50% and 95% probabilities. Conclusion: Different aspects, including gender, higher mast cell load and/or activation, and a stronger atopic background (e.g., coexisting egg allergy, asthma), contributed to the development of anaphylactic reactions to TNs in children.
Article
Background: The prevalence of peanut allergy among children in Western countries has doubled in the past 10 years, and peanut allergy is becoming apparent in Africa and Asia. We evaluated strategies of peanut consumption and avoidance to determine which strategy is most effective in preventing the development of peanut allergy in infants at high risk for the allergy. Methods: We randomly assigned 640 infants with severe eczema, egg allergy, or both to consume or avoid peanuts until 60 months of age. Participants, who were at least 4 months but younger than 11 months of age at randomization, were assigned to separate study cohorts on the basis of preexisting sensitivity to peanut extract, which was determined with the use of a skin-prick test--one consisting of participants with no measurable wheal after testing and the other consisting of those with a wheal measuring 1 to 4 mm in diameter. The primary outcome, which was assessed independently in each cohort, was the proportion of participants with peanut allergy at 60 months of age. Results: Among the 530 infants in the intention-to-treat population who initially had negative results on the skin-prick test, the prevalence of peanut allergy at 60 months of age was 13.7% in the avoidance group and 1.9% in the consumption group (P<0.001). Among the 98 participants in the intention-to-treat population who initially had positive test results, the prevalence of peanut allergy was 35.3% in the avoidance group and 10.6% in the consumption group (P=0.004). There was no significant between-group difference in the incidence of serious adverse events. Increases in levels of peanut-specific IgG4 antibody occurred predominantly in the consumption group; a greater percentage of participants in the avoidance group had elevated titers of peanut-specific IgE antibody. A larger wheal on the skin-prick test and a lower ratio of peanut-specific IgG4:IgE were associated with peanut allergy. Conclusions: The early introduction of peanuts significantly decreased the frequency of the development of peanut allergy among children at high risk for this allergy and modulated immune responses to peanuts. (Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT00329784.).
Article
Background The relationship between early onset eczema and food allergy among infants has never been examined in a population-based sample using the gold standard for diagnosis, oral food challenge.Objective We characterized the risk of challenge-proven food allergy amongst infants with eczema in the general population.Methods One-year-old infants (n= 4453 meeting criteria for this analysis) were assessed for history of eczema, received a nurse-administered eczema exam and underwent skin prick testing to peanut, egg, and sesame. Those with a detectable wheal to one of the test foods underwent an oral food challenge irrespective of wheal size. The risk of food allergy, stratified by eczema severity and age of onset, was estimated using multivariate logistic regression with population sampling weights.ResultsOne in five infants with eczema were allergic to peanut, egg white or sesame, compared to one in twenty-five infants without eczema (OR 6.2, 95% CI 4.9, 7.9, p<0.001). The prevalence of peanut allergy was low in the absence of eczema (0.7% 95% CI 0.4, 1.1). Infants with eczema were 11.0 times more likely to develop peanut allergy (95% CI 6.6, 18.6) and 5.8 times more likely to develop egg allergy (95% CI 4.6, 7.4) by 12 months than infants without eczema. 50.8% of infants (95% CI 42.8, 58.9) with early eczema onset (<3 months) who required doctor-prescribed topical corticosteroid treatment developed challenge-proven food allergy.Conclusion and Clinical RelevanceEczema, across the clinical severity spectrum in infancy, is a strong risk factor for IgE-mediated food allergy. Infants with eczema were 6 times more likely to have egg allergy and 11 times more likely to have peanut allergy by 12 months than infants without eczema. Our data suggest that a heightened awareness of food allergy risk among healthcare practitioners treating infants with eczema, especially if early onset and severe, is warranted.This article is protected by copyright. All rights reserved.